The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Advanced Glycation End Products Inhibit Glucose-Stimulated Insulin Secretion through Nitric Oxide-Dependent Inhibition of Cytochrome c Oxidase and Adenosine Triphosphate Synthesis
Open accessAbstract
Advanced glycation end products (AGEs) are implicated in diabetic complications. However, their role in β-cell dysfunction is less clear. In this study we examined the effects of AGEs on islet function in mice and in isolated islets. AGE-BSA or BSA was administered ip to normal mice twice a day for 2 wk. We showed that AGE-BSA-treated mice exhibited significantly higher glucose levels and lower insulin levels in response to glucose challenge than did BSA-treated mice, although there were no significant differences in insulin sensitivity and islet morphology between two groups. Glucose-stimulated insulin secretion by islets of the AGE-BSA-treated mice or AGE-BSA-treated normal islets was significantly lower than that by islets isolated from the BSA-treated mice or BSA-treated normal islets. Furthermore, AGE treatment of islet β-cells inhibited ATP production, and glimepiride, a sulfonylurea derivative, restored glucose-stimulated insulin secretion. Further investigation indicated that AGEs inhibited cytochrome c oxidase activity by inducing the expression of inducible nitric oxide synthase (iNOS). Blocking the formation of nitric oxide with an iNOS selective inhibitor aminoguanidine reversed the inhibitory effects of AGEs on ATP production and insulin secretion. We conclude that AGEs inhibit cytochrome c oxidase and ATP production, leading to the impairment of glucose-stimulated insulin secretion through iNOS-dependent nitric oxide production.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AGEs also contribute to pancreatic 𝛽-cell dysfunction, another key component in the pathogenesis of T2DM.”
From The Role of Dietary Advanced Glycation End Products in Metabolic Dysfunction (2021) · cites this paper as [137]
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Method for the Isolation of Intact Islets of Langerhans from the Rat Pancreas
Lacy, P. E., & Kostianovsky, M. (1967) · Diabetes · doi:10.2337/diab.16.1.35 · Cited by 2,741
Islet cell failure in type 2 diabetes
Prentki, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29103 · Cited by 1,690
Cleeter, M. W. J., Cooper, J. M., Darley-Usmar, V. M., Moncada, S., & Schapira, A. H. V. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00424-2 · Cited by 1,241
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller‐Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92172 · Cited by 1,113
Brown, G. C., & Cooper, C. E. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)01290-3 · Cited by 1,055
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller‐Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215318 · Cited by 1,006
Koschinsky, T., He, C.-J., Mitsuhashi, T., Bucala, R., Liu, C., Buenting, C., Heitmann, K., & Vlassara, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6474 · Cited by 792
Self-citationDiabetes and advanced glycation endproducts
Vlassara, H., & Palace, M. R. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00932.x · Cited by 723
Self-citationA Lesson in Metabolic Regulation Inspired by the Glucokinase Glucose Sensor Paradigm
Matschinsky, F. (1996) · Diabetes · doi:10.2337/diab.45.2.223 · Cited by 721
Cited by
Sorted by citations
Items 101–132 of 132
Anastasiou, I. A., Tentolouris, K. N., Lambadiari, V., Eleftheriadou, I., Tektonidou, M. G., & Tentolouris, N. (2023) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557523666230510123038 · Cited by 8
Hypoxia in the Diabetic Kidney Is Independent of Advanced Glycation End-Products
Nordquist, L., Liss, P., Fasching, A., Hansell, P., & Palm, F. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4989-8_26 · Cited by 7
Advanced Glycation End Products and Diabetes
Hadzi‐Petrushev, N., Angelovski, M., & Mladenov, M. I. (2023) · Contemporary Endocrinology · doi:10.1007/978-3-031-39721-9_5 · Cited by 7
Zhuang, A., Yap, F. Y. T., McCarthy, D. A., Leung, S. S., Penfold, S. A., Leung, C., Sourris, K. C., Harcourt, B. E., Thallas‐Bonke, V., Coughlan, M. T., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-50221-0 · Cited by 6
Advanced Glycation Endproducts (AGEs) and Chronic Complications in Diabetes
Vlassara, H., & Striker, G. E. (2016) · Springer eBooks · doi:10.1007/978-3-319-20797-1_20-1 · Cited by 5
Self-citationBai, M. R., Abirami, K., Gayathri, R., Vedantham, S., Shobana, S., Nagarajan, L. P., Gunasekaran, G., Gayathri, N., Malini, H. M., Gokulakrishnan, K., et al. (2024) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2024.2405121 · Cited by 7
26. Advanced glycation end products in infant formulas
Šebeková, K., Klenovics, K. S., & Šebeková, K. (2014) · Wageningen Academic Publishers eBooks · doi:10.3920/978-90-8686-223-8_26 · Cited by 5
Wang, Y. J., Wang, X., An, A. X., Zang, M., Xu, L., Gong, K., Song, W., Li, Q., Lu, X., Xiao, Y., et al. (2022) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12760 · Cited by 5
Self-citationShang, S.-W., Jiang-lin, Y., Huang, F., Kang, L. I. U., & Bao-Lin, L. I. U. (2014) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(14)60043-1 · Cited by 5
Tago, K., Inoue, K.-I., Ouchi, M., Miura, Y., & Kubota, K. (2016) · Islets · doi:10.1080/19382014.2016.1212146 · Cited by 4
Role of NADPH Oxidase in Beta Cell Dysfunction
Weaver, J. R., & Taylor, D. (2014) · Springer eBooks · doi:10.1007/978-94-007-6884-0_46-3 · Cited by 4
Li, X., Lu, P., Wan, H., Zhang, W., Jalili, S., & Li, B. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152174 · Cited by 4
Role of NADPH Oxidase in β Cell Dysfunction
Weaver, J. R., & Taylor, D. (2014) · Springer eBooks · doi:10.1007/978-94-007-6686-0_46 · Cited by 2
Koyama, H., & Yamamoto, T. (2012) · InTech eBooks · doi:10.5772/20468 · Cited by 1
AGEs as a Preventable Cause of Diabetes and its Complications
Vlassara, H. (2011) · Cited by 2
Self-citationBorg, D. J., Faridi, P., Giam, K., Reeves, P., Fotheringham, A. K., McCarthy, D. A., Leung, S. S., Ward, M. S., Harcourt, B. E., Ayala, R., et al. (2021) · Metabolites · doi:10.3390/metabo11070426 · Cited by 2
Natural Food Sources for the Control of Glycemia and the Prevention of Diabetic Complications
Pesce, C. M., Iacobini, C., & Menini, S. (2018) · doi:10.1002/9781119436713.ch1 · Cited by 2
Özer, A. (2013) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
A new glycotoxin inhibitor mitigates diabetes in genetic mice model
Khan, G., Aftab, M. F., Murtaza, M., Bano, B., Khan, K. M., & Waraich, R. S. (2018) · International Bhurban Conference on Applied Sciences and Technology (IBCAST) · doi:10.1109/ibcast.2018.8312230 · Cited by 1
Farooqui, A. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819603-8.00005-5 · Cited by 1
Hypoglycemic Drugs and Advanced Glycation End products
(2019) · ARC Journal of Diabetes and Endocrinology · doi:10.20431/2455-5983.0501002 · Cited by 1
Advanced Glycation Endproducts (AGEs) and Chronic Complications in Diabetes
Vlassara, H., & Striker, G. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_20 · Cited by 1
Self-citationDietary Advanced Glycation End-Products (AGES) Induced Complications in Type 1 Diabetes Mellitus
Bhattacharyya, S., & Acharya, S. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1007016 · Cited by 1
Sukino, S., Nirengi, S., Kawaguchi, Y., Kotani, K., Tsuzaki, K., Okada, H., Suganuma, A., & Sakane, N. (2018) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3301w · Cited by 1
Stop the “Vicious Cycle” induced by Glycative Stress.
Yonei, Y., Yagi, M., & Takabe, W. (2020) · doi:10.24659/gsr.7.1_13 · Cited by 1
Diabetes Mellitus y Disfunción Endotelial
Delgado-Butrón, C., Delgado-Torres, C., & Delgado-Torres, L. (2021) · Diagnóstico · doi:10.33734/diagnostico.v59i3.239 · Cited by 1
Wang, X. (2014) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1
Role of NADPH Oxidase in b Cell Dysfunction 34
Weaver, J. R., & Taylor, D. (2015)
Murugan, S. (2016) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v4i5.17
Verzicht auf rotes und verarbeitetes Fleisch verhindert Typ-2-Diabetes
Müssig, K. (2020) · Info Diabetologie · doi:10.1007/s15034-020-2233-8
Zheng, T., Yagi, M., Ogura, M., Terasaka, T., Kuwabara, S., Jinden, T., & Yonei, Y. (2020) · doi:10.24659/gsr.7.3_258
Wang, Y., Wang, X., An, A. X., Zang, M., Xu, L., Gong, K., Xiao, Y., Yu, G., & Zhongmin, A. (2021) · Research Square · doi:10.21203/rs.3.rs-289969/v1
Metadata
- Authors
- Zhao, Z., Zhao, C., Zhang, X. H., Zheng, F., Cai, W., Vlassara, H., & Ma, Z. A.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Zhao, Zhengshan
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2009-02-26
- Volume
- 150
- Issue
- 6
- Pages
- 2569-2576
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- PMC
- PMC2689792
- OpenAlex
- W2081193499
- Cited by
- 132
- References
- 54
- Citations by year
- 2025: 4 · 2024: 4 · 2023: 7 · 2022: 6 · 2021: 6 · 2020: 8 · 2019: 5 · 2018: 7 · 2017: 5 · 2016: 11 · 2015: 6 · 2014: 13 · 2013: 17 · 2012: 12
- FWCI
- 7.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrinology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK063076, R21DK074805, DK074805, DK063076)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- advanced glycation end products, glucose-stimulated insulin secretion, beta-cell dysfunction, cytochrome c oxidase, nitric oxide, inducible nitric oxide synthase, ATP production, islet function, diabetes complications, aminoguanidine, sulfonylureas, AGE-BSA
- MeSH terms
- Insulin Secretion, Adenosine Triphosphate, Animals, Cells, Cultured, Electron Transport Complex IV, Diabetes Mellitus, Disease Models, Animal, Female, Glucose, Insulin, Male, Mice, Inbred C57BL, Nitric Oxide, Glycation End Products, Advanced, Insulin-Secreting Cells, Mice, Nitric Oxide Synthase Type II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
